Article Details
Retrieved on: 2021-06-30 09:00:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The treatment, developed by neuroscience giant Biogen and Japan's Eisai, tackles and reduces a type of protein plaque - known as amyloid beta ...
Article found on: www.investmentweek.co.uk
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here